Global Monoclonal Antibody Therapeutics Market Share

Statistics for the 2023 & 2024 Global Monoclonal Antibody Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Global Monoclonal Antibody Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Monoclonal Antibody Therapeutics Industry

The monoclonal antibody therapeutics market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are acquiring other companies to consolidate their market positions across the globe and while others are launching new products. Some of the companies which are currently dominating the market are Abbvie Inc, Daiichi Sankyo Company Limited, Johnson & Johnson, Amgen Inc, and UCB S.A., Belgium (UCB Inc).

Monoclonal Antibody Therapeutics Market Leaders

  1. Daiichi Sankyo Company Limited

  2. Johnson & Johnson

  3. Abbvie Inc

  4. Amgen Inc

  5. UCB S.A., Belgium (UCB Inc)

*Disclaimer: Major Players sorted in no particular order

Monoclonal Antibody Therapeutics Market Concentration

Monoclonal Antibody Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)